Changes in performance of the Pari eFlow rapid and Pari LC Plus during 6 months use by CF patients.

@article{Rottier2009ChangesIP,
  title={Changes in performance of the Pari eFlow rapid and Pari LC Plus during 6 months use by CF patients.},
  author={Bart L. Rottier and Cyril J P van Erp and Tanya S Sluyter and Harry G. M. Heijerman and Henderik Willem Frijlink and Anne H. de Boer},
  journal={Journal of aerosol medicine and pulmonary drug delivery},
  year={2009},
  volume={22 3},
  pages={263-9}
}
BACKGROUND Nebulized antibiotics are important in the treatment of cystic fibrosis. The Pari eFlow rapid with vibrating mesh is often used off-label for the administration of tobramycin (TOBI) because of a reduced nebulization time and easier handling compared to a classic nebulizer-compressor combination. Mesh technology may be vulnerable, however. Therefore, we investigated particle size distribution and output as well as changes in the performance of the eFlow before and after 6 months of… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 19 extracted citations

Similar Papers

Loading similar papers…